CINECA IRIS Institutional Research Information System

CHIELLINI, GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.679
AS - Asia 7.065
EU - Europa 6.211
SA - Sud America 962
AF - Africa 292
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 29.227
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.234
IT - Italia 2.326
SG - Singapore 2.126
CN - Cina 2.030
HK - Hong Kong 1.198
SE - Svezia 999
BR - Brasile 779
VN - Vietnam 583
DE - Germania 562
BG - Bulgaria 474
CA - Canada 357
FR - Francia 307
UA - Ucraina 276
TR - Turchia 273
GB - Regno Unito 270
FI - Finlandia 244
RU - Federazione Russa 206
KR - Corea 187
AT - Austria 178
JP - Giappone 176
IN - India 155
CH - Svizzera 137
CI - Costa d'Avorio 128
AR - Argentina 63
BD - Bangladesh 60
PL - Polonia 46
MX - Messico 40
NL - Olanda 37
IQ - Iraq 36
PK - Pakistan 34
ZA - Sudafrica 32
BE - Belgio 31
ID - Indonesia 30
MA - Marocco 29
EC - Ecuador 27
ES - Italia 27
SA - Arabia Saudita 27
CO - Colombia 21
SN - Senegal 21
PE - Perù 20
CZ - Repubblica Ceca 19
UZ - Uzbekistan 19
KE - Kenya 17
NG - Nigeria 17
VE - Venezuela 15
EG - Egitto 14
GR - Grecia 14
MY - Malesia 14
CL - Cile 13
IR - Iran 13
PH - Filippine 13
AE - Emirati Arabi Uniti 11
AZ - Azerbaigian 10
CR - Costa Rica 10
IE - Irlanda 10
JO - Giordania 10
PY - Paraguay 10
TN - Tunisia 10
UY - Uruguay 9
AU - Australia 8
IL - Israele 8
JM - Giamaica 8
NP - Nepal 8
AL - Albania 7
EU - Europa 7
NO - Norvegia 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
AF - Afghanistan, Repubblica islamica di 6
OM - Oman 6
PT - Portogallo 6
BJ - Benin 5
DZ - Algeria 5
KZ - Kazakistan 5
LT - Lituania 5
PA - Panama 5
BB - Barbados 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
HN - Honduras 3
KG - Kirghizistan 3
KW - Kuwait 3
LU - Lussemburgo 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
RO - Romania 3
AO - Angola 2
BO - Bolivia 2
BW - Botswana 2
CG - Congo 2
DK - Danimarca 2
ET - Etiopia 2
GT - Guatemala 2
GY - Guiana 2
HU - Ungheria 2
KH - Cambogia 2
LB - Libano 2
LV - Lettonia 2
RS - Serbia 2
Totale 29.206
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.678
Ashburn 1.350
Ann Arbor 1.296
Singapore 1.242
Hong Kong 1.181
San Jose 873
Chandler 831
Houston 810
Fairfield 800
Dallas 740
Milan 704
Santa Clara 612
Sofia 473
Shanghai 429
Beijing 423
Jacksonville 388
Wilmington 343
Serra 306
Seattle 304
New York 303
Ottawa 272
Cambridge 260
Boardman 249
Hefei 230
Princeton 229
Pisa 219
Lawrence 183
Los Angeles 183
Seoul 182
Izmir 173
Tokyo 169
Lauterbourg 165
Nanjing 164
Vienna 163
Medford 156
Ho Chi Minh City 151
Abidjan 128
Bern 118
Frankfurt am Main 102
Rome 101
Hanoi 98
Council Bluffs 94
Des Moines 88
Buffalo 85
Dong Ket 81
Istanbul 76
Dearborn 75
Jüchen 70
Redondo Beach 69
Helsinki 65
London 65
Nanchang 65
São Paulo 60
Florence 57
Munich 53
San Diego 49
Columbus 47
Kunming 47
Chicago 43
Redwood City 42
Carrara 41
The Dalles 37
Hebei 36
Bremen 35
Pune 35
Ogden 33
Orem 33
Marseille 32
Warsaw 32
Brussels 30
Montreal 29
Lucca 27
Norwalk 27
Hyderabad 25
Jiaxing 25
Middleton 24
Nuremberg 24
Shenyang 24
Tianjin 24
Boulder 23
Haiphong 23
Livorno 23
Rio de Janeiro 23
Boston 22
San Francisco 22
Dakar 21
Johannesburg 21
Turku 21
Brasília 20
Da Nang 20
Belo Horizonte 19
Düsseldorf 19
Phoenix 19
Changsha 18
Chennai 18
Denver 18
Falls Church 18
Hangzhou 18
Washington 18
Guangzhou 17
Totale 21.006
Salva come PNG Salva come JPEG
Nome #
Effects of Thyroid Hormones and their Metabolites on Learning and Memory in Normal and Pathological Conditions 263
A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor 248
Dual inhibition of PDK1 and Aurora Kinase A: an effective strategy to induce differentiation and apoptosis of human glioblastoma multiforme stem cells 231
Ultrastructural Localization of Histidine-rich Glycoprotein in Skeletal Muscle Fibers: Colocalization With AMP Deaminase 231
Memantine prodrug as a new agent for alzheimer’s disease 226
Modulation of Gene Expression by 3-Iodothyronamine: Genetic Evidence for a Lipolytic Pattern 215
The pleiotropic functionality of endogenous 3-iodothyronamine (T1AM) and synthetic thyronamine-like analogs: a powerful tool to target interlinked diseases such as obesity and neurodegeneration 213
3-Iodothyronamine affects calcium handling in rat ventricular cardiomyocytes 212
Development and primary characterization of a human thyroid organoid in vitro model for thyroid metabolism investigation 208
3-Iodothyronamine modulates sarcoplasmic reticulum calcium release 206
The [(Methyloxy)imino]methyl Moiety as a Bioisoster of Aryl. A Novel Class of Completely Aliphatic Beta-Adrenergic Receptor Antagonists 206
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 202
3-Iodothyronamine as a novel endogenous chemical messenger: tissue distribution and catabolism 202
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands 202
Cardioprotective effect of 3-iodothyronamine in perfused rat heart subjected to ischemia and reperfusion. 201
Endogenous TH metabolite 3-iodothyronamine (T1AM) and synthetic thyronamine-like analogues SG-1 and SG-2 induce autophagy in human glioblastoma cells (U-87MG) 199
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2 197
(Z)-(Methyloxyiminomethyl)ethanolamines. Effects of the configuration around the iminic double bond on the beta-adrenergic affinity of moim-type beta-adrenergic blocking agents 192
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 192
New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection 189
Cardioprotection by 3-iodothyronamine, a new endogenous chemical messenger 188
Conformationally Restrained Analogs of Sympathomimetic Catecholamines. Synthesis, Conformational Analysis, and Adrenergic Activity of Isochroman Derivatives 188
3-Iodothyronamine as a Novel Endogenous Chemical Messenger: Tissue Distribution and Catabolism. 187
Conformationally restrained ß-blocking oxime ethers. 2. Synthesis and ß-adrenergic properties of diastereoisomeric anti and syn 2-(5’-(3’-aryl-substituted)isoxazolidinyl)-N-alkylethanolamines 186
Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylase 186
Synthesis and ß-adrenergic properties of (E)-N-[3-(alkylamino)-2- hydroxypropilidene](methyloxy)amines substituted with an aromatic group on their [(methyloxy)imino]methyl moiety (MOIMM): an investigation into the biopharmacological effects of an aryl substitution in the class of MOIM ß-blocking drugs. 185
3-Iodothyronamine (T(1)AM) induces variation in phosphorylation pattern of tyrosine residues in rat heart 184
3-iodothyronamine as a potential anti-tumor compound 184
Metabolic reprogramming by 3-Iodothyronamine (T1AM): a new perspective to reverse obesity through co-regulation of sirtuin 4 and 6 expression 182
3-Iodothyronamine affects calcium handling in isolated cardiomyocytes 181
An efficient substitution reaction for the preparation of thyroid hormone analogues 180
Endogenous 3-iodothyronamine (T1Am) and synthetic thyronamine-like analog SG-2 act as novel pleiotropic neuroprotective agents through the modulation of SIRT6 179
Thyroid hormone-sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific 178
Different configurations of specific thyroid hormone response elements mediate opposite effects of thyroid hormone and GC-1 on gene expression 177
Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors 176
Electron microscope localization of A1 adenosine receptors in human neutrophils 174
WEIGHT LOSS WITH PRESERVED GLUCOSE HOMEOSTASIS DURING CHRONIC TREATMENT OF OBESE MICE WITH 3-IODOTHYRONAMINE (T1AM): ROLE OF THE SIRTUIN FAMILY 173
In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine 173
3-Iodothyronamine Modulates Sarcoplasmic Reticulum Calcium Release 172
The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas 172
Cardioprotection by ranolazine in perfused rat heart 172
A new signalling pathway mediated by 3-iodothyronamine in rat heart 171
2-methylene-19-nor-(23S)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone 171
Modulation of Cardiac Inotropic State by 3-Iodothyronamine: Evidence for a Novel Signalling Pathway Mediated by Trace Amine-Associated Receptors 170
Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors. 170
Design of thyroid hormone receptor antagonists from first principles 170
Synthesis and ß-Adrenergic Properties Of (Z)-N-[3-(Alkylamino)-2-hydroxypropilidene](aryl-methyloxy)amines: Effects Of The Configuration Around The Methyloxyiminomethyl(MOIM) Double Bond On The Biopharmacological Properties Of MOIM-type ß-Blocking Agents 169
2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs 169
Delivery of thyronamines (Tams) to the brain: A preliminary study 169
Effects of Zofenopril on Cardiac Sarcoplasmic Reticulum Calcium Handling 167
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 167
FLUORESCENT PROBE SPECIFICALLY LABELS A1 ADENOSINE RECEPTOR IN BOVINE CORONARY ARTERY. 166
Sintesi e proprietà beta-adrenergiche di [(benzilideneammino)ossi] propanolammine orto-ossipropanolammine sostituite chirali, 165
Administration of 3-Iodothyronamine (T1AM) Affects Gene Expression in the Rat Adipose Tissue Cells. 165
Cardiac effects of trace amines: Pharmacological characterization of trace amine-associated receptors 165
Deciphering the potential of 3-iodothyronamine (T1AM) in regulating lipid metabolism 165
3-iodothyronamine is a novel endogenous modulator of cardiac inotropic state 164
The importance of stereochemistry on the actions of vitamin D. 164
3-Iodothyronamine (T1AM) modifies tyrosine phosphorylation pattern in rat heart 163
Evaluation of 3-iodothyronamine (T1AM) in cell preparation, tissue homogenates and biological fluids by HPLC-ESI-MS-MS 161
New Insights into the Effects of 3-Iodothyronamine (T1AM) on Metabolism in Mice from Cavity Ring Down Spectroscopy (CRDS) 161
SG‐2: A SYNTHETIC ANALOG OF THYROID HORMONE METABOLITE 3‐IODOTHYRONAMINE (T1AM), PREVENTS β‐AMYLOID NEUROTOXICITY IN VITRO 161
ADENOSINE RECEPTORS: NEW PERSPECTIVE BY THE USE OF AGONIST-DERIVED MOLECULAR PROBES. 160
The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer's Disease 158
3-Iodothyronamine (T1AM) signalling pathway involves tyrosine phosphorylation in rat heart 158
3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells. 158
3-Iodothyronamine (T1AM) induces variation in the phosphorylation pattern of thyrosine residues in rat heart 157
The TR-beta selective agonist, GC-1, stimulates mitochondrial oxidative processes to a lesser extent than triiodothyronine 157
Tissue Distribution and Cardiac Metabolism of 3-Iodothyronamine 157
(E)-(ARYLMETHYLENEAMINOXY)ACETAMIDES AS ANALOGS OF NEUROLEPTIC BENZAMIDES - SYNTHESIS AND D-2-DOPAMINERGIC BINDING-AFFINITY 156
Synthesis and biological properties of 2-methylene-19-nor-25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones--weak agonists 155
A-ring analogs of 1,25-dihydroxyvitamin D-3 155
Synthesis and Biological Evaluation of Cyclopropylamine Vitamin D‐Like CYP24A1 Inhibitors 154
Discovery of pyridoquinoxaline-based new P-gp inhibitors as coadjutant against Multi Drug Resistance in cancer 153
Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine 153
Modulation of cardiac inotropic state by 3-iodothyronamine: evidence for a novel signalling pathway mediated by trace amine-associated receptors 152
2-methylene-(20S,25S)-19,26-dinor-vitamin D analogs 152
Quantification of serum 25-hydroxyvitamin D: a comparison among immunoassay, HPLC-UV, and HPLC-MS 152
Cardiac effects of thyronamines 152
A NOVEL HPLC-MS-MS METHOD TO ASSAY TISSUE THYROID HORMONES 152
Recovery of 3-iodothyronamine and derivatives in biological matrices: problems and pitfalls 152
Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders 152
An Efficient Aequorea victoria Green Fluorescent Protein for Stimulated Emission Depletion Super-Resolution Microscopy 152
Synthesis and biological activity of novel thyroid hormone analogues: 5 '-aryl substituted GC-1 derivatives 151
Cardiac metabolism of 3-iodothyronamine 151
Removal of the 26-methyl group from 19-nor-1a,25-dihydroxyvitamin D3 markedly reduces in vivo calcemic activity without altering in vitro VDR binding, HL-60 cell differentiation, and transcription. 151
Modulation of cardiac calcium homeostasis by 3-iodothyronamine 151
Performance in Behavioral Testing in an Animal Model of Post-Surgical Hypoparathyroidism 151
Multi-targeted ChEI-copper chelating molecules as neuroprotective agents 150
Optical imaging of mitochondrial redox state in rodent models with 3-iodothyronamine. 149
2-methylene-19-nor-(23S)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro 1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone 148
Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function 148
Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis 147
New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective 147
Effects of 3-Iodothyronamine on Sarcoplasmic Reticulum Calcium Release in Rat Heart 146
Effect of 3-iodothyronamine on myocardial calcium homeostasis 145
New insights into the thyroid endocrine system by HPLC-ESI-MS-MS 145
SUN-717 SG-2 a Novel Multi-Target Directed Ligand (MTDL) for the Treatment of Neurodegenerative Diseases (NDDS) 145
8.1.4 – Biological Vesicles and Platforms – Cyclodextrin-based platforms as RNA delivery systems 143
2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs 143
Totale 17.263
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.125
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.034 36 127 45 133 383 292 43 89 87 86 134 579
2022/20232.682 387 337 192 265 290 373 14 172 446 16 116 74
2023/20242.446 429 278 275 213 346 344 88 75 36 46 50 266
2024/20255.534 36 236 103 264 476 493 501 305 577 827 638 1.078
2025/20267.063 466 869 861 752 601 608 1.025 277 503 506 381 214
2026/202790 90 0 0 0 0 0 0 0 0 0 0 0
Totale 29.608